We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTV icon
826
Aptiv
APTV
$12.6B
$6K ﹤0.01%
37
+6
+19% +$934
MDT icon
827
Medtronic
MDT
$111B
$6K ﹤0.01%
51
+14
+38% +$1.81K
TM icon
828
Toyota
TM
$221B
$6K ﹤0.01%
35
-2
-5% -$357
BBVA icon
829
Banco Bilbao Vizcaya Argentaria
BBVA
$147B
$4K ﹤0.01%
602
+295
+96% +$1.91K
BHP icon
830
BHP
BHP
$213B
$4K ﹤0.01%
92
+8
+10% +$489
GSK icon
831
GSK
GSK
$108B
$4K ﹤0.01%
74
– –
RDS.A
832
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$4K ﹤0.01%
100
+9
+10% +$363
GRMN
833
Garmin
GRMN
$48.9B
$3K ﹤0.01%
18
+1
+6% +$163
TT icon
834
Trane Technologies
TT
$104B
$3K ﹤0.01%
17
-5
-23% -$962
ACN icon
835
Accenture
ACN
$101B
$2K ﹤0.01%
6
+2
+50% +$651
EQNR icon
836
Equinor
EQNR
$90.9B
$2K ﹤0.01%
59
-7
-11% -$150
ETN icon
837
Eaton
ETN
$150B
$2K ﹤0.01%
16
– –
NVO
838
Novo Nordisk
NVO
$225B
$2K ﹤0.01%
46
-10
-18% -$483
RIO icon
839
Rio Tinto
RIO
$149B
$2K ﹤0.01%
27
+6
+29% +$468
TEF
840
DELISTED
Telefonica
TEF
$2K ﹤0.01%
387
-260
-40% -$1.16K
TEL icon
841
TE Connectivity
TEL
$62.1B
$2K ﹤0.01%
18
– –
BBL
842
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$2K ﹤0.01%
45
+22
+96% +$1.32K
BP icon
843
BP
BP
$107B
$1K ﹤0.01%
45
-2
-4% -$50
IX icon
844
ORIX
IX
$42.8B
$1K ﹤0.01%
+55
New +$1.01K
LIN icon
845
Linde
LIN
$236B
$1K ﹤0.01%
5
– –
MRUS
846
DELISTED
Merus
MRUS
$1K ﹤0.01%
47
+3
+7% +$64
SMFG icon
847
Sumitomo Mitsui Financial
SMFG
$163B
$1K ﹤0.01%
138
+1
+0.7% +$7
TAK icon
848
Takeda Pharmaceutical
TAK
$56B
$1K ﹤0.01%
76
-2
-3% -$34
TTE icon
849
TotalEnergies
TTE
$187B
$1K ﹤0.01%
20
+5
+33% +$222
VOD icon
850
Vodafone
VOD
$37.7B
$1K ﹤0.01%
71
+16
+29% +$265
32 33
34
35 36

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.